| Literature DB >> 29541448 |
Nicholas Agyepong1, Usha Govinden1, Alex Owusu-Ofori2, Sabiha Yusuf Essack1.
Abstract
Background: Multidrug-resistant Gram-negative bacteria have emerged as major clinical and therapeutic dilemma in hospitals in Ghana.To describe the prevalence and profile of infections attributable to multidrug-resistant Gram-negative bacteria among patients at the Komfo Anokye Teaching Hospital in the Ashanti region of Ghana.Entities:
Keywords: Antibiotic resistance; Infections; Multidrug resistance; Pathogens
Mesh:
Substances:
Year: 2018 PMID: 29541448 PMCID: PMC5845144 DOI: 10.1186/s13756-018-0324-2
Source DB: PubMed Journal: Antimicrob Resist Infect Control ISSN: 2047-2994 Impact factor: 4.887
Distribution of isolates among clinical specimen, wards and diagnosis
| Isolates ( | |||||||||
|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
| Other* | Total (%) | |
| Specimen | |||||||||
| Asctic fluid | – | – | – | – | – | – | – | 1 | 1 (0.5) |
| Aspirate | – | 2 | 1 | 1 | – | – | – | – | 4 (2.0) |
| Blood | – | 1 | 2 | 2 | – | – | – | 6 | 11 (5.5) |
| Bronchial Lavage | – | – | 1 | – | – | – | – | – | 1 (0.5) |
| Ear Swab | – | 1 | – | 1 | 1 | 1 | – | 2 | 6 (3.0) |
| Gastric Lavage | – | – | – | 1 | 1 | – | – | 2 | 4 (2.0) |
| Nasal Swab | – | – | – | – | 1 | – | – | – | 1 (0.5) |
| Pleural Fluid | – | – | – | 1 | – | – | 1 | – | 2 (1.0) |
| Pus | – | 3 | – | – | – | – | 1 | 1 | 5 (2.5) |
| Sputum | – | 3 | 3 | 3 | 8 | 3 | 2 | 2 | 24 (12.0) |
| Urethral Swab | 2 | – | – | – | – | – | – | – | 2 (1.0) |
| Urine | 6 | 35 | 5 | 23 | 12 | 4 | 4 | 5 | 94 (47.0) |
| Wound Swab | – | 4 | 6 | 16 | – | 3 | 16 | 45 (22.5) | |
| WARD/DEPT | |||||||||
| A &E | 1 | 2 | – | 2 | 2 | 1 | 1 | 1 | 10 (5.0) |
| Child Health | 1 | 12 | 3 | 11 | 3 | – | 1 | 8 | 39 (19.5) |
| Medical ICU | 2 | 14 | 6 | 10 | 21 | 5 | 4 | 16 | 78 (39.0) |
| OBS &GYN | 2 | 3 | 2 | 4 | 2 | 1 | 1 | 2 | 17 (8.5) |
| OPD | 2 | 12 | 1 | 9 | 5 | 1 | 3 | 6 | 39 (19.5) |
| Surgery | – | 6 | – | 2 | 6 | – | – | 3 | 17 (8.5) |
| Diagnosis | |||||||||
| Abscess | – | 1 | 1 | 1 | 1 | 1 | – | 2 | 7 (3.5) |
| Appendicitis | – | 1 | – | – | – | – | – | – | 1 (0.5) |
| Bacteremia | – | 1 | – | – | – | – | – | – | 1 (0.5) |
| Bronchitis | – | – | – | 1 | 1 | – | – | – | 2 (1.0) |
| Cellulitis | – | – | – | – | – | – | – | 1 | 1 (0.5) |
| Cirrhosis | – | 1 | 1 | – | – | – | – | – | 2 (1.0) |
| Cystitis | – | – | – | 1 | – | – | – | – | 1 (0.5) |
| Diabetic foot ulcer | – | 1 | 1 | – | 4 | – | 1 | 3 | 10 (5.0) |
| Gastroenteritis | – | 4 | – | 1 | – | – | – | – | 5 (2.5) |
| Nephritis | – | 6 | – | 3 | – | 1 | – | 1 | 11 (5.5) |
| Otitis | – | 1 | – | – | – | – | – | 1 | 2 (1.0) |
| Pericarditis | – | 1 | – | – | 2 | – | – | – | 3 (1.5) |
| Peritonitis | – | 1 | – | – | 1 | – | – | – | 2 (1.0) |
| Pneumoniae | – | – | – | 1 | – | 2 | 1 | – | 4 (2.0) |
| Prostitis | – | – | – | – | – | 1 | – | – | 1 (0.5) |
| RTI | – | – | – | 1 | 1 | – | 2 | 1 | 5 (2.5) |
| Sepsis | 1 | 6 | 1 | 4 | 4 | 2 | 3 | 8 | 29 (14.5) |
| Surg. site infection | – | 1 | – | 4 | 4 | – | – | 1 | 10 (5.0) |
| Tuberculosis | – | 1 | 4 | 2 |
| 1 | 1 | 2 | 18 (9.0) |
| UTI | 7 | 24 | 4 | 17 | 9 | – | 2 | 6 | 69 (34.5) |
| Ulcer | – | – | – | – | 1 | – | – | 1 | 2 (1.0) |
| Wound infection | – | – | – | 1 | 4 | – | – | 7 | 12 (6.0) |
| Frequency (%) |
|
|
|
|
|
|
|
|
|
Abbreviation: A&E Accident and Emergency, OPD Out-Patient Department, OBS&GYN Obstetrics and Gynecology, Other* Other Gram-negative bacteria. The In-Patient Department comprises of A&E, Medical ICU, OBS&GYN and Surgical ward, −: Non-detected
Distribution of infections among gender and patients’ age groups
| Age (Years) | ||||||||
|---|---|---|---|---|---|---|---|---|
| < 10 | 10–19 | 20–29 | 30–39 | 40–49 | 50–59 | ≥60 | Total (%) | |
| Gender | ||||||||
| Female | 21 | 8 | 20 | 13 | 11 | 9 | 17 | 99 (49.5) |
| Male | 27 | 11 | 6 | 8 | 9 | 8 | 32 | 101 (50.1) |
| Infections | ||||||||
| Abscess | 2 | 1 | 2 | 1 | – | 1 | – | 7 (3.5) |
| Appendicitis | – | 1 | – | – | – | – | – | 1 (0.5) |
| Bacteremia | 1 | – | – | – | – | – | – | 1 (0.5) |
| Bronchitis | 1 | – | – | – | – | – | 1 | 2 (1.0) |
| Cellulitis | – | – | – | – | – | – | 1 | 1 (0.5) |
| Cirrhosis | – | 1 | 1 | – | – | – | – | 21.0) |
| Cystitis | 1 | – | – | – | – | – | – | 1 (0.5) |
| Diabetic foot ulcer | – | – | 1 | – | 1 | 1 | 7 | 10 (5.0) |
| Gastroenteritis | 4 | 3 | – | – | – | – | – | 7 (3.5) |
| Nephritis | – | 1 | 1 | 1 | 1 | 1 | 6 | 11 (3.5) |
| Otitis | 1 | – | 1 | – | – | – | – | 2 (1.0) |
| Pericarditis | – | – | – | – | 2 | – | 1 | 3 (1.5) |
| Peritonitis | 2 | – | – | – | – | – | – | 2 (1.0) |
| Pneumoniae | – | 1 | – | – | – | – | 3 | 4 (2.0) |
| Prostitis | – | – | – | – | – | – | 1 | 1 (1.0) |
| RTI | 2 | 1 | – | 1 | 1 | – | – | 5 (2.5) |
| Sepsis | 8 | 3 | 1 | – | 1 | 2 | 5 | 20 (10.0) |
| Surgical wound infection | 1 | 1 | 2 | 2 | – | 2 | 2 | 10 (5.0) |
| Tuberculosis | 1 | 1 | 3 | – | 6 | 3 | 4 | 18 (9.0) |
| UTI | 23 | 4 | 10 | 12 | 7 | 4 | 9 | 69 (34.5) |
| Ulcer | – | 1 | – | – | 1 | – | – | 2 (1.0) |
| Wound infection | 1 | – | 2 | 2 | 1 | 2 | 2 | 10 (5.0) |
| Frequency (%) |
|
|
|
|
|
|
|
|
Abbreviation: UTI Urinary tract infection, RTI Respiratory tract infection, −: Non-detected
Antibiotic susceptibility profile of isolates
| Antibiotics | Total number of isolates ( | Susceptible | Intermediate | Resistant |
|---|---|---|---|---|
| Ampicillin | 162 | 7 (4.3) | 2 (1.2) | 153 (94.4) |
| Amox/clav | 200 | 51 (25.5) | 47 (23.5) | 102 (51.5) |
| Piperacillin-tazobactam | 198 | 109 (54.5) | 62 (31.0) | 27 (13.5) |
| Cefuroxime | 200 | 35 (17.5) | 7 (3.5) | 158 (79.0) |
| Cefoxitin | 200 | 74 (37.0) | 11 (5.5) | 115 (57.5) |
| Cefotaxime | 199 | 44 (22.1) | 12 (6.0) | 143 (71.3) |
| Ceftazidime | 200 | 104 (52.0) | 15 (7.5) | 81 (40.5) |
| Cefepime | 200 | 119 (59.5) | 64 (32.0) | 17 (8.5) |
| Ertapenam | 132 | 130 (98.5) | 1 (0.8) | 1 (0.8) |
| Imipenem | 199 | 191 (95.5) | 0 (0.0) | 8 (4.0) |
| Meropenem | 198 | 192 (97.0) | 1 (0.5) | 5 (2.5) |
| Amikacin | 199 | 178 (89.4) | 14 (7.0) | 7 (3.5) |
| Gentamicin | 198 | 105 (53.0) | 5 (2.5) | 88 (44.4) |
| Ciprofloxacin | 200 | 116 (58.0) | 2 (1.0) | 82 (41.0) |
| Tetracycline | 199 | 124 (62.3) | 14 (7.0) | 61 (30.7) |
| Nitrofuratoin | 200 | 84 (42.0) | 17 (8.5) | 99 (49.5) |
| Collistin | 198 | 164 (82.8) | 2 (1.0) | 32 (16.2) |
| Trim/Sulfamethoxazole | 200 | 31 (15.5) | 0 (0.0) | 169 (84.5) |
Not all the antibiotics were tested for all 200 isolates and not all N-values added up to 200
Abbreviation: amox/clav amoxicillin-clavulanate, trim/sulfamethoxazole trimethoprim-sulfamethoxazole
MDR among Isolates
| Bacterial Isolates | Number of Isolates ( | MDR |
|---|---|---|
|
| 8 | 8 (100.0) |
|
| 49 | 44 (89.9) |
|
| 12 | 7 (53.8) |
|
| 38 | 36 (94.7) |
|
| 39 | 39 (100.0) |
|
| 8 | 7 (87.5) |
|
| 10 | 9 (90.0) |
| Other Gram negative | 36 | 29 (80.6) |
| Frequency |
|
|